BIVI
Biovie Inc
NASDAQ · Biotechnology
$1.13
+0.07 (+6.60%)
Open$1.11
Previous Close$1.06
Day High$1.18
Day Low$1.08
52W High$27.00
52W Low$11.50
Volume—
Avg Volume221.8K
Market Cap8.52M
P/E Ratio28.83
EPS$0.79
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,482.3% upside
Current
$1.13
$1.13
Target
$29.18
$29.18
$17.82
$29.18 avg
$40.31
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.45M | 8.50M | 8.91M |
| Net Income | 239.2K | 243.9K | 245.4K |
| Profit Margin | 2.5% | 2.9% | 2.8% |
| EBITDA | 403.0K | 435.3K | 434.6K |
| Free Cash Flow | 313.2K | 273.2K | 249.3K |
| Rev Growth | +19.1% | +23.4% | +6.1% |
| Debt/Equity | 0.60 | 0.55 | 0.53 |
Dividend
Dividend Yield2.98%
Annual Dividend$0.68
Payout Ratio86.5%
Frequencyquarterly
Ex-DividendApr 12, 2026
Pay DateApr 24, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |